Particularly, the proliferation class is characterized by more aggressive clinical and biological features, higher incidence of tumor relapse and shorter survival, increased cellular proliferation, activation of pro-survival, anti-apoptotic pathways mediated by MET and E2F1, larger and less differentiated tumors, various types of genetic abnormalities associated with loss of TP53 function [75]. This evidence concerns the gene TP53 and neoplasm.